Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Prostate Cancer

In brief

RATIONALE: Vaccines made from tumor cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This randomized phase II trial is studying vaccine therapy to see how well it works compared with a placebo in treating patients with stage D0 prostate cancer.

Key facts

Study ID

NCT00514072

Run by

Kael-GemVax Co., Ltd.

People needed

54

Starts

2007-03-01

Last updated by the study team

2012-08-09

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.